Free Trial
NYSE:NGVT

Ingevity (NGVT) Stock Price, News & Analysis

$35.36
-1.21 (-3.31%)
(As of 09/6/2024 ET)
Today's Range
$35.12
$36.90
50-Day Range
$34.54
$47.24
52-Week Range
$33.49
$56.29
Volume
230,822 shs
Average Volume
238,725 shs
Market Capitalization
$1.28 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$51.33

Ingevity MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
45.2% Upside
$51.33 Price Target
Short Interest
Healthy
2.49% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.45mentions of Ingevity in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
44.49%
From $2.63 to $3.80 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.89 out of 5 stars

Basic Materials Sector

109th out of 180 stocks

Chemicals & Allied Products Industry

10th out of 14 stocks

NGVT stock logo

About Ingevity Stock (NYSE:NGVT)

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, paper chemicals, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts and components manufacturers through sales representatives and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

NGVT Stock Price History

NGVT Stock News Headlines

10 Best Specialty Chemical Stocks To Buy Now
Who are Nvidia’s New Silent Partners?
Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.
Ingevity: The Risk-Reward Ratio Is Still Unfavorable
DQ Sep 2024 14.000 call (DQ240920C00014000)
Oversold Conditions For Ingevity (NGVT)
Q2 2024 Ingevity Corp Earnings Call Transcript
Who are Nvidia’s New Silent Partners?
Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.
Unveiling 4 Analyst Insights On Ingevity
Here's what to expect from Ingevity's earnings
See More Headlines
Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/31/2024
Today
9/07/2024
Next Earnings (Estimated)
11/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
Chemicals
Previous Symbol
NASDAQ:NGVT
Employees
1,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$51.33
High Stock Price Target
$62.00
Low Stock Price Target
$40.00
Potential Upside/Downside
+45.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
6 Analysts

Profitability

Pretax Margin
-34.13%

Debt

Sales & Book Value

Annual Sales
$1.55 billion
Cash Flow
$6.61 per share
Book Value
$7.84 per share

Miscellaneous

Free Float
35,929,000
Market Cap
$1.28 billion
Optionable
Optionable
Beta
1.66
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. John C. Fortson (Age 57)
    President, CEO & Director
    Comp: $1.29M
  • Ms. Mary Dean Hall (Age 66)
    Executive VP & CFO
    Comp: $658.77k
  • Ms. Stacy Lancaster Cozad (Age 53)
    Executive VP, General Counsel & Secretary
    Comp: $615.75k
  • Mr. Stuart Edward Woodcock Jr.Mr. Stuart Edward Woodcock Jr. (Age 58)
    Executive VP & President of Performance Materials
    Comp: $823.8k
  • Mr. Richard A. White Jr. (Age 61)
    Senior VP & President of Performance Chemicals
    Comp: $575.57k
  • Mr. Phillip John Platt (Age 43)
    VP, Chief Accounting Officer & Business Transformation Lead
  • John E. Nypaver Jr.
    VP of Investor Relations & Treasurer
  • Caroline Monahan
    Director of Communications
  • Mr. Steven P. Hulme (Age 55)
    Senior VP & President of Advanced Polymer Technologies

NGVT Stock Analysis - Frequently Asked Questions

How have NGVT shares performed this year?

Ingevity's stock was trading at $47.22 at the beginning of the year. Since then, NGVT shares have decreased by 25.1% and is now trading at $35.36.
View the best growth stocks for 2024 here
.

How were Ingevity's earnings last quarter?

Ingevity Co. (NYSE:NGVT) posted its quarterly earnings data on Wednesday, July, 31st. The company reported $1.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.05 by $0.04. The firm's revenue for the quarter was down 18.9% compared to the same quarter last year.

What is John Fortson's approval rating as Ingevity's CEO?

2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com. John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are Ingevity's major shareholders?

Top institutional shareholders of Ingevity include Thrivent Financial for Lutherans (3.74%), Victory Capital Management Inc. (2.83%), LSV Asset Management (2.33%) and Dimensional Fund Advisors LP (2.33%). Insiders that own company stock include Stuart Edward Jr Woodcock, Erik Spencer Ripple, Richard Allen White Jr and Phillip John Platt.
View institutional ownership trends
.

How do I buy shares of Ingevity?

Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), WestRock (WRK), Abbott Laboratories (ABT) and Boeing (BA).

This page (NYSE:NGVT) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners